Clopidogrel genes and PPI
Links shared publicly online about this topic.
- 1,044total visits
Clopidogrel genes and PPI
View full resource at theheart.org
Tags: Genes, Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on July 5, 2010 at 9:45 pm By:
New meta-analysis: CYP2C19*2 carriers at higher risks of events on clopidogrel: The analysis also looked at the ef... http://bit.ly/d1uIcH
Clopidogrel and adverse cardiovascular events not linked - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – There is no need to avoid proton pump inhibitors (PPIs) in patients on the platelet inhibitors clopidogrel or ticagrelor. The increased rates of adverse cardiovascular events in these patients are tied to baseline status rather than any drug...” View full resource at thedoctorschannel.com
Most Recently Shared on February 27, 2012 at 7:31 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
Don't jump to conclusions ... especially in matters of the heart! - From Reuters Health/TDC http://t.co/cy2Q0cr0 #health #heart #PPI
MedWire News - Thrombosis - Early stent thrombosis predictors identified
medwire-news.md — “MedWire News Variants in three genes associated with clopidogrel metabolism and platelet receptor function are independently associated with early stent thrombosis in patients undergoing percutaneous coronary intervention, study data show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on October 27, 2011 at 9:25 am By:
Early stent thrombosis predictors identified http://t.co/e1Dcb2dA
Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy : Article : Nature Reviews Cardiology
nature.com — “Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy : Article : Nature Reviews Cardiology” View full resource at nature.com
Most Recently Shared on January 11, 2011 at 1:20 am By:
Symposier Cardiology Cardiology and Health Business
Antiplatelet therapy: Clopidogrel–PPI interaction, an ongoing controversy. http://bit.ly/hJs1U7
Next Steps in Pharmacogenomics: Topol on Genomics
boards.medscape.com — “A new, potentially quite important, variant of the gene PON1 influencing Plavix (clopidogrel) metabolism was just reported in Nature Medicine with an accompanying editorial that I prepared with my colleague Dr. Nicholas Schork. This discovery is inst” View full resource at boards.medscape.com
Most Recently Shared on January 8, 2011 at 8:27 pm By:
westr Doctor, Health Social Media, and PhD
PON1-variant Reflections: "Some v-blog thoughts on progress in pharmacogenomics http://bit.ly/gysK4E" -via @EricTopol 4' vid #PM101
Next Steps in Pharmacogenomics: Topol on Genomics
boards.medscape.com — “A new potentially quite important variant of the gene PON1 influencing Plavix (clopidogrel) metabolism was just reported in Nature Medicine with an accompanying editorial that I prepared with my colleague Dr. Nicholas Schork. This discovery is instru” View full resource at boards.medscape.com
Most Recently Shared on January 8, 2011 at 8:19 pm By:
Eric Topol, MD Cardiologist, Physician, Doctor, and Internist
Some v-blog thoughts on progress in pharmacogenomics http://bit.ly/gysK4E
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures
eurekalert.org — “An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary stent placement have an associated increased risk for major adverse cardiovascular events, particularly development of blood clots in stents, according to a study in the Oct. 27 issue of JAMA.” View full resource at eurekalert.org
Most Recently Shared on October 26, 2010 at 9:34 pm By:
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures: ( JAMA and Arc... http://bit.ly/94oABn
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds - Drugs.com MedNews
drugs.com — “People with certain gene variants who take the blood-thinning drug Plavix (clopidogrel) may be at increased risk for serious complications after coronary stent” View full resource at drugs.com
Most Recently Shared on October 26, 2010 at 9:29 pm By:
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds - http://bit.ly/cTT53h
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds - Drugs.com MedNews
drugs.com — “People with certain gene variants who take the blood-thinning drug Plavix (clopidogrel) may be at increased risk for serious complications after coronary stent” View full resource at drugs.com
Most Recently Shared on October 26, 2010 at 9:13 pm By:
Drugs and Devices OW OW Health
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds: TUESDAY, Oct. 26 -- People with certain gene va... http://bit.ly/bkpa2p #drug
PolygenicBlog: Visceral Adiposity Index Directly Correlated To Viral Load In Genotype 1 Chronic Hepatitis C
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on October 23, 2010 at 11:37 pm By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter Doctor, Medical Technology, Pharmacist, and PhD
Visceral Adiposity Index Directly Correlated To Viral Load In Genotype 1 Chronic Hepatitis C http://goo.gl/fb/PpyWK
Vanderbilt clopidogrel gene testing | theheart.org
theheart.org — “Heartwire staff and renowned specialists in cardiology from Duke Clinical Research Institute and Mayo Clinic discuss latest developments in interventional surgery.” View full resource at theheart.org
Most Recently Shared on October 21, 2010 at 10:56 pm By:
Eric Topol, MD Cardiologist, Physician, Doctor, and Internist
Another major center-Vanderbilt--now doing routine genotyping for Plavix loss of function variants http://bit.ly/9ZZ18k
Vanderbilt clopidogrel gene testing | theheart.org
theheart.org — “Heartwire staff and renowned specialists in cardiology from Duke Clinical Research Institute and Mayo Clinic discuss latest developments in interventional surgery.” View full resource at theheart.org
Most Recently Shared on October 21, 2010 at 8:20 pm By:
Vanderbilt now also routinely gene testing for clopidogrel metabolizer status: But the medical center has gone one... http://bit.ly/d827gX
COGENT Published: Lead Investigator Says He'll Use a PPI in Patients on Dual Antiplatelet Therapy - QualityPoint Technologies
qualitypointtech.net — “Patients on dual antiplatelet therapy had a significant reduction in GI events with omeprazole and no increase in cardiovascular events in the first randomized trial of PPI use with clopidogrel. And a new mechanistic study suggests that the clopidogrel-omeprazole interaction may be dose dependent. Heartwire” View full resource at qualitypointtech.net
Most Recently Shared on October 7, 2010 at 11:36 pm By:
COGENT Published: Lead Investigator Says He'll Use a PPI in Patients on Dual Antiplatelet Therapy: Patients on du... http://bit.ly/diVT5k
Medical News: PPI Gives Big Protection in Dual Antiplatelet Tx - in Cardiovascular, PCI from MedPage Today
medpagetoday.com — “A pill that combines omeprazole and clopidogrel as part of a dual antiplatelet regimen significantly reduced the risk of gastrointestinal bleeding or other adverse events compared with standard therap” View full resource at medpagetoday.com
Most Recently Shared on October 7, 2010 at 1:27 am By:
PPI Gives Big Protection in Dual Antiplatelet Tx (CME/CE) http://ow.ly/19k6RF
PPI Gives Big Protection in Dual Antiplatelet Tx (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A pill that combines omeprazole and clopidogrel as part of a dual antiplatelet regimen significantly reduced the risk of gastrointestinal bleeding or other adverse events compared with standard therapy, researchers reported.” View full resource at qualitypointtech.net
Most Recently Shared on October 6, 2010 at 10:00 pm By:
PPI Gives Big Protection in Dual Antiplatelet Tx (CME/CE): (MedPage Today) -- A pill that combines omeprazole and ... http://bit.ly/aOrEGk
Symposier - ESC Congress 2010 by topic: from genes to CV outcomes
symposier.com — “Uploaded and shared in Youtube by: escardiodotorg " ESC 2010 Congress Spotlight by Fausto Pinto, CPC Chairman Impact of genotype on outcomes in the CURE ACTIVE study (Efficacy and Safety of Clopidogrel compared with Placebo according to CYP2C19 Genotype in over 6000 patients with Non-ST-elevation Acute Coronary Syndromes and atrial fibrillation) (Guillaume Par, Hamilton) Genetic profiling: ready for clinical use? (Gilles Montalescot, Paris) Genetic determinants of treatment benefit of ACE-inhibi” View full resource at symposier.com
Most Recently Shared on September 27, 2010 at 10:58 pm By:
Symposier Cardiology Cardiology and Health Business
ESC Congress 2010 by topic: from genes to CV outcomes. http://bit.ly/ccYuWW
Advertisement
